Search clinical trials for: FDG-PET guided dose painting

Total 918 results

Turku University Hospital

Completed

Imaging of Joint Replacement Complications by PET/CT (Propeli)

Infection of Total Hip Joint Prosthesis | Adverse Reactions to Metal Debris | Mechanical Loosening of Prosthetic Joint

Finland
Université de Sherbrooke
Canadian Cancer Society (CCS); Fonds de la Recherche en Santé du Québec; Merck... and other collaborators

Completed

3TMPO (Triple-Tracer Strategy Against Metastatic Prostate Cancer

Metastatic Castration-resistant Prostate Cancer

Canada
Hadassah Medical Organization

Unknown

Contribution of F18-FDG PET/CT to the Early Assessment of Pazopanib Therapy Efficacy in Advanced Soft Tissue Sarcoma

Soft Tissue Sarcoma (STS)

Israel
Affiliated Cancer Hospital & Institute of Guangzhou...

Not yet recruiting

18F-FAPI and 18F-FDG PET/CT in Patients With Various Types of Cancer (FAPI-VTC)

Cancer
Celal Bayar University

Completed

The Role of 68GA DOTATATE PET/CT In Breast Cancer Imaging

Breast Cancer

Turkey
Memorial Sloan Kettering Cancer Center

Active, not recruiting

Positron Lymphography Via Intracervical 18F-FDG Injection for Pre-surgical Lymphatic Mapping in Stage IB1 Cervical Cancer and High-grade Endometrial Cancer

Cervical Cancer | Endometrial Cancer

United States
Ateneo de Manila University
University of Oxford; University of Cape Town; Bangor University; UNICEF; Philippine... and other collaborators

Completed

Parenting for Lifelong Health (PLH) - Masayang Pamilya (MaPa) Evaluation Study (PLH-MaPa)

Child Maltreatment

Philippines
The Cleveland Clinic

Completed

Chest Imaging, Breath, and Biomarkers in a Screening Trial

Lung Cancer

United States
Abramson Cancer Center of the University of Pennsylvania

Completed

Detection and Quant of Differences in Hodgkin Lymphoma and Diffuse Large B-cell Lymphoma Using Positron Emission Tomography/Computed Tomography (PET/CT)

Lymphoma

United States
Institut de cancérologie Strasbourg Europe

Not yet recruiting

Simultaneous Integrated Boost FDOPA Positron Emission Tomography (PET) Guided in Patients With Partially- or Non-operated Glioblastoma (SIB-DOPA)

Glioblastoma Multiforme, Adult
University Medical Center Groningen
M.D. Anderson Cancer Center

Not yet recruiting

PIRATES: Image-guided Hyper-fractioned Dose-escalation With Proton Therapy for Head and Neck Cancer (PIRATES)

Head and Neck Cancer | Oropharyngeal Cancer

Netherlands
Institut de cancérologie Strasbourg Europe

Recruiting

Contribution of PET/MRI in Locally Advanced Cervical Cancer (ATICC) (ATICC)

Cervical Cancer

France
Vestre Viken Hospital Trust

Recruiting

18F-FDG PET/CT Imaging for Breast Cancer

Breast Cancer Recurrent | Breast Cancer Female

Norway
University Hospital, Brest

Not yet recruiting

Impact of Local Tissue Inflammation on Intramyocardial Conduction Pathways Post Percutaneous Valve : Evaluation by Positron Emission Tomography on Exploratory Cohort (IMPACT)

Aortic Valve Stenosis

France
Douglas Scharre
Avid Radiopharmaceuticals; Mangurian Foundation

Recruiting

Distinguishing Between Alzheimer's Disease, Lewy Body Dementia, and Parkinson's Disease

Parkinson's Disease | Alzheimer's Disease | Lewy Body Dementia

United States
University of Lausanne Hospitals

Terminated

Per-operating Use of a Probe for Detection of β+

Neoplasms

Switzerland
Central Hospital, Nancy, France

Completed

Characterization in 18F-FDG PET-CT of Brain and Lung Lesions in Subjects With a History of Severe COVID-19 (TEP-COV)

Covid-19

France
Assiut University

Completed

Role of Positron Emission Tomography/ Computed Tomography (PET/CT) and in Bone Metastases. (PET/CT)

Bone Metastases

Egypt
Centre Hospitalier Universitaire de Nīmes

Completed

Metabolic Anomolies Associated With the 6 Month Clinical Evolution of Patients Suffering From Motor Conversion Disorder (HYCORE)

Conversion Disorder

France
Peking University Cancer Hospital & Institute

Unknown

18F-FDG PET/CT-based Prognostic Model for Predicting Outcome in Patients With Diffuse Large B-cell Lymphoma

Lymphoma, Large B-Cell, Diffuse

China
Merck Sharp & Dohme LLC

Terminated

A Study to Evaluate [18F]-FDG PET (Fluorodeoxyglucose-positron) in Patients With Pancreatic Cancer (MK-0000-144)

Advanced Pancreatic Adenocarcinoma
University Hospital, Brest
Canadian Institutes of Health Research (CIHR); Ministry of Health, France; Ottawa...

Recruiting

Screening for Occult Malignancy in Patients With Unprovoked Venous Thromboembolism (MVTEP2/SOME2)

Embolism and Thrombosis

France, Canada
Assistance Publique Hopitaux De Marseille

Completed

Diagnostic Value of 18F-fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Prosthetic Valve Endocarditis

Prosthetic Valve Endocarditis (PVE)

France
Centre hospitalier de l'Université de Montréal...

Terminated

Comparison of FDG PET and Bone Scintigraphy/Labelled Leukocyte/Gallium Scintigraphy in Diabetic Foot Osteomyelitis

Diabetic Foot Infection

Canada
Tri-Service General Hospital

Completed

PET Imaging of Hemophilic Arthropathy

Inflammation | Hemophilia | Arthropathy

Taiwan
Assistance Publique - Hôpitaux de Paris
Institut National de la Santé Et de la Recherche Médicale, France; Institut... and other collaborators

Completed

Hepatosplenic CANdidiasis : PETscan and Immune Response Analysis (CANHPARI)

Neutropenia | Hematopoietic Stem Cell Transplantation | Hematological Malignancies | Invasive Fungal Disease | Chronic Disseminated Candidiasis

France
Svendborg Hospital
Odense University Hospital

Unknown

Polymyalgia Rheumatica and Giant Cell Arteritis

Giant Cell Arteritis | Polymyalgia Rheumatica

Denmark
University of Aarhus

Completed

Early Changes in Positron Emissions Tomography (PET/CT) Scan as Predictors of Clinical Outcome in NSCLC Treated With EGFR Tyrosin Kinase Inhibitors (TKI)

Non-small Cell Lung Cancer Patients

Denmark
Peking University Cancer Hospital & Institute
Beijing Municipal Administration of Hospitals

Unknown

18F-FDG PET/CT-based Prognostic Model for Predicting Outcome in Patients With Peripheral T-cell Lymphoma

Lymphoma, T-Cell, Peripheral

China
Peking University Cancer Hospital & Institute
Beijing Municipal Administration of Hospitals

Unknown

18F-FDG PET/CT-based Prognostic Model for Predicting Outcome in Patients With Natural Killer/T-cell Lymphoma

Lymphoma, Extranodal NK-T-Cell

China
Universitaire Ziekenhuizen KU Leuven

Completed

Early Metabolic Response in Locally Advanced Esophageal Cancer Undergoing Induction Chemoradiotherapy

Esophageal Carcinoma (Squamous Cell Carcinoma - Adenocarcinoma)

Belgium
Air Force Military Medical University, China

Unknown

Comparison of Two Methods for Bowel Preparation in Patients With Constipation

Health Behavior

China
Siemens Molecular Imaging

Terminated

[F-18] RGD-K5 Positron Emission Tomography (PET) in Participants With Carotid Artery Stenosis

Carotid Stenosis

United States
National Cancer Institute (NCI)

Completed

Romidepsin in Treating Patients With Recurrent and/or Metastatic Thyroid Cancer That Has Not Responded to Radioactive Iodine

Recurrent Thyroid Cancer | Stage IV Follicular Thyroid Cancer | Stage IV Papillary Thyroid Cancer

United States
New York State Psychiatric Institute
National Institute of Mental Health (NIMH)

Completed

Antepartum Study on Use of Interpersonal Psychotherapy at 3 New York City Site

Depression

United States
Jinling Hospital, China

Not yet recruiting

To Compare the Clinical Application of 18F-LNC1007 Injection PET/CT and 18F-FDG PET/CT (18F-LNC1007)

Tumour
University of Wisconsin, Madison
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

Not yet recruiting

FDG PET/MR Imaging of Peripheral Pain Generators

Pain | Nociceptive Pain

United States
Wuhan Union Hospital, China

Recruiting

A Study of the Value of Hybrid PET/MR and PET/CT in Prostate Cancer

Prostate Cancer | PET/MR | PET/CT

China
National Cancer Institute (NCI)

Completed

Imaging in MGUS, SMM and MM

Multiple Myeloma | Monoclonal Gammopathy of Undetermined Significance | Smoldering Multiple Myeloma

United States
British Columbia Cancer Agency

Withdrawn

FDGal PET/CT to Detect Hepatocellular Carcinoma

Liver Cirrhosis | Hepatocellular Carcinoma | Chronic Liver Disease

Canada
University Health Network, Toronto

Recruiting

PET/MR Pre- and Post Radiotherapy for Cardiopulmonary Dysfunction Evaluation

Pulmonary Hypertension

Canada
NYU Langone Health

Active, not recruiting

Diffusion MRI for Head and Neck Cancer

Head Cancer Neck

United States
Chang Gung Memorial Hospital

Completed

Prognostic Utility of the Imaging and Biological Signatures in Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma
Peking University Cancer Hospital & Institute

Unknown

Evaluating 18F-FDG PET/CT With Liver SUVmax-based Criteria for Prognosis of Patients With Diffuse Large B-cell Lymphoma

Lymphoma, Large B-Cell, Diffuse

China
British Columbia Cancer Agency

Not yet recruiting

Preliminary Assessment of [18F]BL40 in PET/CT Scans

Multiple Myeloma | Waldenström Macroglobulinemia | Mantle Cell Lymphoma | Marginal Zone Lymphoma | Chronic Lymphocytic Leukemia | Diffuse Large B-cell Lymphoma

Canada
Boston Children's Hospital
National Institutes of Health (NIH)

Enrolling by invitation

Pain in Fibrous Dysplasia

Fibrous Dysplasia/McCune-Albright Syndrome

United States
Insel Gruppe AG, University Hospital Bern

Recruiting

Assessing Ultra-low Dose PET/CT and CT-less PET Using a Long Axial Field-of-view PET/CT System (ULD-PET)

PET/CT

Switzerland
University of Southern California
National Cancer Institute (NCI)

Terminated

18F-FMAU PET/CT in Imaging Patients With Advanced Cancers

Malignant Neoplasm

United States
National Cancer Institute (NCI)

Completed

Saracatinib in Treating Patients With Previously Treated Metastatic Pancreatic Cancer

Adenocarcinoma of the Pancreas | Recurrent Pancreatic Cancer | Stage IV Pancreatic Cancer

United States, Singapore, Australia
Perfuse Therapeutics, Inc.

Recruiting

A Study of PER-001 in Participants With Diabetic Retinopathy

Diabetic Retinopathy

United States

Search clinical trials for: FDG-PET guided dose painting

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Norway

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations